Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Lecardio AS
AS
Active
Org 990988226
Wieses Gate 3, 2609
Lillehammer
Medical specialists activities
·
NACE 8622
Est. 2007 · 19 years old
2 employees
Monitor
Share
Norway
/
Companies
/
Medical specialists activities
/
Lecardio AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
12M
9M
6M
3M
0M
2021: 8M
8M
2021
2022: 9M (+13% vs 2021)
9M
+13%
2022
2023: 9M (0% vs 2022)
9M
0%
2023
2024: 10M (+11% vs 2023)
10M
+11%
2024
2025: 10M (0% vs 2024)
10M
0%
2025
EBITDA
NOK millions
7M
6M
4M
2M
0M
2021: 2M
2M
2021
2022: 4M (+100% vs 2021)
4M
+100%
2022
2023: 4M (0% vs 2022)
4M
0%
2023
2024: 6M (+50% vs 2023)
6M
+50%
2024
2025: 6M (0% vs 2024)
6M
0%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
10 092
9 718
8 709
8 810
8 167
Staff expenses
−2 395
−2 483
−3 734
−4 351
−5 655
EBITDA
6 425
6 251
3 916
3 555
1 531
Depreciation & amort.
−433
−387
−396
−417
−570
EBIT
5 992
5 863
3 519
3 138
961
Net financials
1 839
2 403
1 543
−599
744
Profit before tax
7 831
8 266
5 062
2 539
1 705
Tax
1 221
1 167
733
690
212
Net profit
6 609
7 100
4 329
1 849
1 493
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
47 503
43 546
37 231
25 175
24 070
Equity
35 365
31 756
26 656
22 327
21 178
Long-term debt
0
8 055
8 395
0
0
Short-term debt
5 623
3 735
2 179
2 848
2 892
Total debt
12 138
11 790
10 574
2 848
2 892
Financial ratios
5-year trend
EBITDA margin
63,7 %
This company
15,8 %
Market median
This company
Market median
303% above market
2021
2025
Equity ratio
74,4 %
This company
38,2 %
Market median
This company
Market median
95% above market
2021
2025
Return on equity
18,7 %
This company
18,4 %
Market median
This company
Market median
2% above market
2021
2025
Net profit margin
65,5 %
This company
8,1 %
Market median
This company
Market median
709% above market
2021
2025
Asset turnover
0,21×
This company
1,12×
Market median
This company
Market median
81% below market
2021
2025
Debt / equity
0,34×
This company
0,62×
Market median
This company
Market median
45% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Lecardio AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
